Valiant Laboratories IPO

Valiant Laboratories IPO will open for subscription from 27 September 2023. The company aims for an issue size of ₹152.46 Cr through this IPO.

Company Overview

Full nameValiant Laboratories Limited
IndustryPharmaceuticals & Drugs
Company Website

About Company

Incorporation in 2021, Valiant Laboratories is an Active Pharmaceutical Ingredient (API) / Bulk Drug manufacturing company focusing on the manufacturing of Paracetamol. Bulk drugs/APIs serve as raw materials for manufacturing finished dosage forms or formulations. Valiant Laboratories manufacturing facility is located at Palghar, in the state of Maharashtra, India which is spread over an aggregate parcel of land admeasuring about 2,000 sq. mts. with an aggregate annual total installed capacity of 9,000 MT per annum.

For the financial year ended 31 March 2023, 2022, and 2021, the revenue from sales outside India contributed 0.39%, 0.60 %, and 0.33 %, respectively of the total revenue from operations. The revenue from operations grew at a CAGR of 23.90% between FY 2017 and FY 2023. The restated profit after tax, grew at a CAGR of 26.81% between FY 2017 and FY 2023.

The Objectives of the Issue

  • Investment in its wholly-owned subsidiary, Valiant Advanced Sciences Private Limited (VASPL) for part-financing its capital expenditure requirements in relation to the setting up of a manufacturing facility for specialty chemicals at Saykha Industrial Area, Bharuch, Bharuch, Gujarat (Proposed Facility).
  • Investment in VASPL for funding its working capital requirements.
  • General corporate purposes.

IPO Timetable

IPO Opening date27 September 2023
IPO Closing03 October 2023
Basis of Allotment06 October 2023
Initiation Refund09 October 2023
Credit to Demat Account10 October 2023
Listing Date11 October 2023
(Cut-off time for UPI mandate confirmation – 5 PM on October 3, 2023)

IPO details

Issue typeBook Built Issue IPO
IPO issue size₹152.46 Cr – 10,890,000 shares
Fresh Issue₹152.46 Cr – 10,890,000 shares
Offer for saleNil
Face value₹10 per share
Price Band Offer Price₹133 to ₹140 per share
Lot size105 Shares
Shareholding pre-issue32,560,000
Shareholding post-issue44,116,000
Listing ExchangeBSE & NSE

IPO Lot Size

Retail (Min)1105₹14,700
Retail (Max)131365₹191,100
S-HNI (Min)141,470₹205,800
S-HNI (Max)687,140₹999,600
B-HNI (Min)697,245₹1,014,300

Reservation Details

QIB Shares Offered50%
NII (HNI) Shares Offered15%
Retail Shares Offered35%

Financial Performance

 FY 2021FY 2022FY 2023
Net income4.7522.5929.03
Margin (%)5.7710.808.69
(Amount in ₹ Crores)

Valuations & Margins

FY 2021FY 2022FY 2023
PE ratio
RONW (%)34.5438.4828.86
ROCE (%)70.8635.7522.76
EBITDA (%)27.4214.5210.51

Company Promoters

  • Shantilal Shivji Vora
  • Dhanvallabh Ventures LLP (DVL)

Promoter Holding

Pre Issue Share Holding100%
Post Issue Share Holding74.94%

Lead Manager(s)

A/305, Dynasty Business Park, Andheri Kurla Road,
Andheri East, Mumbai 400059, Maharashtra
Phone:+91 98200 57533

IPO Registrar

C-101, 1st Floor, 247 Park
L.B.S. Marg, Vikhroli West
Mumbai – 400 083, Maharashtra
Phone: +91 22 4918 6200

Contact Details

104, Udyog Kshetra, Mulund Goregaon Link Road,
Mulund West, Mumbai- 400080, Maharashtra
Phone: +91-22-4971 2001

Allotment Status

Valiant Laboratories IPO allotment will be available on Link Intime’s website. Click on this link to get allotment status.

Final thoughts

Valiant Laboratories IPO is going to hit Dalal Street soon. applying for an IPO is purely a personal choice. study well about the company and subscribe if you are feeling good about the company. I hope this post will give you enough details to make a fundamental study of the company. learn well and make wise decisions.

Happy Investing

Leave a Comment

Your email address will not be published. Required fields are marked *